Ask The Recruiter
Adapt my resume

Standard BioTools Inc.

Funding reported, $30M, last update 3 weeks ago

Pharma biotech · Headquarters Boston, United States

Everything we hold on Standard BioTools Inc., newest first. Every line links to the filing or report it came from.

4 updates tracked
$30M disclosed funding
2 leadership changes
28 May 2026 tracked since
Boston, United States where

This profile is thin because we hold 4 source documents on Standard BioTools Inc. so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.

  1. 2026-07-28
    Headcount Not Stated Growing and expanding

    Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

    Standard BioTools, based in Boston, Mass., is selling its mass cytometry business to Multiplex Bio and using Illumina's $30 million buyout of contingent payments to advance its merger with Treeline Biosciences, with the dedicated CyTOF and Hyperion team continuing under the new owner. The filing states no hiring plans for the merged pharma and biotech entity.

    Boston, United States · $30M raised · Official Filing · SEC EDGAR

  2. 2026-06-18
    Pay Change Leadership moves

    Standard BioTools Inc. 8-K filing (Item 5.02): officer or director change

    Standard BioTools has modified its equity and stock purchase plans, offering more shares to participants.

    Boston, United States · Official Filing · SEC EDGAR

  3. 2026-06-03
    Pay Change Pay and benefits

    Standard BioTools Inc. Grants Restricted Stock Units to Chief Business Officer

    Sean Mackay, Chief Business Officer, receives a significant equity grant in Boston. The filing does not disclose broader hiring plans; watch the company's careers page for executive roles.

    Boston, United States · Official Filing · SEC EDGAR

  4. 2026-05-28
    Headcount Not Stated Leadership moves

    STANDARD BIOTOOLS INC. 8-K filing (Item 5.02): officer or director change

    Standard BioTools' executive team is covered by a new severance plan in Boston, with no disclosed changes to headcount.

    Boston, United States · Official Filing · SEC EDGAR

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker